Phio Pharmaceuticals Corp. (PHIO)
NASDAQ: PHIO · Real-Time Price · USD
2.120
-0.040 (-1.85%)
Oct 29, 2025, 10:48 AM EDT - Market open
Phio Pharmaceuticals Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
5
Market Cap
12.14M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
PHIO News
- 8 days ago - Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series - Newsfile Corp
- 5 weeks ago - Phio Pharmaceuticals to Present at the Life Sciences Future Conference - Newsfile Corp
- 2 months ago - Phio Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference - Newsfile Corp
- 2 months ago - Phio Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update - Newsfile Corp
- 3 months ago - Phio Pharmaceuticals Announces Exercise of Warrants for Approximately $2.5 Million Gross Proceeds - Newsfile Corp
- 3 months ago - Phio Pharmaceuticals Announces Pathology Results for Four of Five Patients in Fourth Cohort - Newsfile Corp
- 3 months ago - Phio Pharmaceuticals Announces Agreement with U.S. Manufacturing Source for Drug Substance - Newsfile Corp
- 4 months ago - Phio Pharmaceuticals Announces Positive Safety Monitoring Committee Recommendation to Advance INTASYL PH-762 Skin Cancer Clinical Trial to Fifth Dose Escalation Cohort - Newsfile Corp